YSU awarded first clinical drug study, for kidney disease

YOUNGSTOWN

A pharmaceutical company awarded a $70,000 grant to a Canfield physician and a Youngstown State University professor for a clinical drug study — a first for the university.

The study will evaluate the effect of drug treatment on patients with chronic kidney disease who have been on dialysis for less than five years.

Martin Abraham, interim provost and vice president for academic affairs, said the grant and YSU’s participating in the study is an indication of YSU’s continued evolution as a research university.

The grant from Mallinckrodt Pharmaceuticals, a global company, was awarded to Dr. Erdal Sarac, medical director at the Centers for Dialysis Care in Canfield, and Jane Wetzel, a YSU associate professor of physical therapy.

Read more about the study in Thursday's Vindicator or on Vindy.com.